- Home
- TPB vs HROW Comparison
TPB vs HROW Comparison
Compare TPB & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPB
- HROW
- Stock Information
- Founded
- TPB 1988
- HROW 1998
- Country
- TPB United States
- HROW United States
- Employees
- TPB N/A
- HROW N/A
- Industry
- TPB Tobacco
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- TPB Consumer Discretionary
- HROW Health Care
- Exchange
- TPB Nasdaq
- HROW Nasdaq
- Market Cap
- TPB 1.3B
- HROW 1.1B
- IPO Year
- TPB 2016
- HROW N/A
- Fundamental
- Price
- TPB $73.87
- HROW $31.78
- Analyst Decision
- TPB Strong Buy
- HROW Strong Buy
- Analyst Count
- TPB 4
- HROW 6
- Target Price
- TPB $73.75
- HROW $59.00
- AVG Volume (30 Days)
- TPB 310.6K
- HROW 376.1K
- Earning Date
- TPB 07-31-2025
- HROW 08-06-2025
- Dividend Yield
- TPB 0.41%
- HROW N/A
- EPS Growth
- TPB N/A
- HROW N/A
- EPS
- TPB N/A
- HROW N/A
- Revenue
- TPB $384,032,000.00
- HROW $212,858,000.00
- Revenue This Year
- TPB $21.66
- HROW $44.92
- Revenue Next Year
- TPB $9.08
- HROW $38.12
- P/E Ratio
- TPB $31.34
- HROW N/A
- Revenue Growth
- TPB 24.54
- HROW 53.49
- 52 Week Low
- TPB $32.54
- HROW $20.85
- 52 Week High
- TPB $81.25
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- TPB 50.87
- HROW 60.19
- Support Level
- TPB $70.75
- HROW $29.78
- Resistance Level
- TPB $76.54
- HROW $32.46
- Average True Range (ATR)
- TPB 2.82
- HROW 1.35
- MACD
- TPB -0.48
- HROW -0.17
- Stochastic Oscillator
- TPB 29.71
- HROW 74.18
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.